Description

This funding opportunity from the Crohn's & Colitis Foundation aims to accelerate the development of innovative, non-surgical therapies for fibrotic complications in inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. The program specifically seeks translational, product-oriented research—such as small molecules, biologics, gene or cell therapies, or novel devices—that addresses the significant unmet need for effective treatments for fibrostenosis in IBD patients. Proposals should be grounded in clinical observations or published human IBD evidence and must demonstrate a clear path toward commercialization.